<SEC-DOCUMENT>0001387131-21-004073-index.html : 20210331
<SEC-HEADER>0001387131-21-004073.hdr.sgml : 20210331
<ACCEPTANCE-DATETIME>20210331163805
ACCESSION NUMBER:		0001387131-21-004073
CONFORMED SUBMISSION TYPE:	NT 10-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210331
DATE AS OF CHANGE:		20210331
EFFECTIVENESS DATE:		20210331

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adamis Pharmaceuticals Corp
		CENTRAL INDEX KEY:			0000887247
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				820429727
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		NT 10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36242
		FILM NUMBER:		21793992

	BUSINESS ADDRESS:	
		STREET 1:		11682 EL CAMINO REAL
		STREET 2:		SUITE 300
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		(858) 997-2400

	MAIL ADDRESS:	
		STREET 1:		11682 EL CAMINO REAL
		STREET 2:		SUITE 300
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELLEGY PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19950615
</SEC-HEADER>
<DOCUMENT>
<TYPE>NT 10-K
<SEQUENCE>1
<FILENAME>admp-nt10k_123120.htm
<DESCRIPTION>NOTICE UNDER RULE 12B25 OF INABILITY TO TIMELY FILE
<TEXT>
Document 1 - file: admp-nt10k_123120.htm

</DOCUMENT>
</SEC-DOCUMENT>